(Photo by Natalia KOLESNIKOVA / AFP / FILE PHOTO / MANILA BULLETIN)
During a briefing conducted by the Committee on People’s Participation chaired by San Jose del Monte City Rep. Florida Robes, Russian embassy officials, together with Olivia Limpe-Aw, the local distribution partner Sputnik V manufacturers, also guaranteed cooperation in the submission of Philippine government requirements for the procurement of the vaccine.
Russian Embassy Minister Counselor Valdlen V. Epifanov and First Secretary (Trade) Vladislav S. Mongush were quick to assure lawmakers that state-run Gamaleya National Center of Epidemiology and Microbiology will be able to meet the Philippines requirement for Sputnik V.
“The results of the clinical trial phase 3 conducted last year showed its very high safety and efficacy rate which has been recognized by the very respectable British Lancet medical journal. As far as its efficacy, it goes up to 91.6 percent and volunteers of 60 (years of age) and up is a little bit higher (at) 91.8 percent. 98 percent of those vaccinated developed good immune response,” said Epifanov.